DGAP-News: Eckert&Ziegler: A profitable First Quarter in 2011
(firmenpresse) - DGAP-News: Eckert&Ziegler Strahlen- und Medizintechnik AG / Key
word(s): Quarter Results
Eckert&Ziegler: A profitable First Quarter in 2011
03.05.2011 / 07:45
---------------------------------------------------------------------
Berlin, May 03, 2011. The first quarter of 2011 was extremely successful
for the Eckert&Ziegler Group (ISIN DE0005659700), a specialist for
isotope applications in medicine, science and industry. Sales in all
segments were higher than in the first quarter of 2010, rising in total by
EUR 2.5 million (10%) to EUR 28.2 million. This is the second highest
figure ever reached for sales during a quarter, surpassed only by the
immediately preceding fourth quarter of 2010 when a special project in
Russia accounted for an exceptionally high proportion of turnover and a
total of EUR 30.0 million EUR was achieved.
Profits grew even more vigorously than sales, also increasing in all
operative segments and setting new absolute records. In no previous quarter
had the group achieved an EBIT of EUR 6.4 million, a profit before tax of
EUR 6.0 million, and a net income after minority interests of EUR 3.6
million. In comparison with the first quarter of the previous year EBIT
grew by 23%, profit before tax increased by 25% and net income after
minority interests was up by 44%. Earnings per share for the first quarter
of 2011 stood at EUR 0.69.
Once again Isotope Products accounted for the biggest proportion of overall
earnings. Admittedly, revenue was up by only 7% but roughly half of the
revenue increase of EUR 0.9 million was achieved as profit because the
increase in the cost items was disproportionately low.
The strongest growth was achieved by the Radiopharma segment where sales
were up by at least 25% in every product group. Overall, the segment
increased its quarterly revenue by 31% to EUR 6.2 million. What is
particularly gratifying in this context is the gross margin of 62%, the
highest throughout the group, so that it is in this segment that a major
part of the revenue growth is reflected in profit, even more so than in the
Isotope Products segment.
Sales were also up in the Therapy segment. The afterloaders developed
particularly well. Detailed statements concerning the Therapy segment can
be found in the quarterly report of IBt S.A. (www.ibt-bebig.eu) which is
being released concurrently.
Sales also rose in the Environmental Services segment, although only by EUR
0.1 million because new orders had not yet materialised in revenue. Some
small savings were achieved as far as the costs are concerned so that, in
contrast to the previous year, there were no more losses.
The board of directors and supervisory board will suggest a dividend of
0.60 per share (previous year: EUR 0.45) at the Annual General Meeting on
19th May 2011.
Sales of between EUR 110 and 120 million and a result after tax and
minority interests of at least EUR 10 million are expected for the fiscal
year 2011. By the end of 2014 the board of directors is expecting a
profitable increase in sales to around EUR 200 million per year.
With around 550 employees the Eckert&Ziegler Group belongs to the largest
providers of isotope components for radiotherapy and nuclear medicine
worldwide.
End of Corporate News
---------------------------------------------------------------------
03.05.2011 Dissemination of a Corporate News, transmitted by DGAP - a
company of EquityStory AG.
The issuer is solely responsible for the content of this announcement.
DGAP's Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de
---------------------------------------------------------------------
Language: English
Company: Eckert&Ziegler Strahlen- und Medizintechnik AG
Robert-Rössle-Str.10
13125 Berlin
Deutschland
Phone: 49 30 941084-138
Fax: 49 30 941084-112
E-mail: karolin.riehle(at)ezag.de
Internet: www.ezag.de
ISIN: DE0005659700
WKN: 565970
Listed: Regulierter Markt in Frankfurt (Prime Standard), Stuttgart;
Freiverkehr in Berlin, Düsseldorf, Hamburg, München
End of News DGAP News-Service
---------------------------------------------------------------------
122478 03.05.2011
Datum: 03.05.2011 - 07:45 Uhr
Sprache: Deutsch
News-ID 33941
Anzahl Zeichen: 0
contact information:
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 186 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"DGAP-News: Eckert&Ziegler: A profitable First Quarter in 2011"
steht unter der journalistisch-redaktionellen Verantwortung von
Eckert&Ziegler Strahlen- und Medizintechnik AG (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
